Pascal Viguié is the CEO and co-founder of bYoRNA, a biotech startup specializing in the production of therapeutic mRNA using yeast fermentation. Pascal was previously a high tech investor and entrepreneur. He sold his first company, 321Auto/Mixad, to Price Minister (now Rakuten) for over 40m USD. He then supported, as a manager or key investor, several startups that have achieved revenues of over 50m USD and created hundreds of jobs. Pascal holds a MSc in nanomedicine from the University of Oxford after an engineering degree at Ecole Polytechnique, France (eq. to BSc in biology & chemistry). He completed his education with an MBA from Columbia Business School.